Patents by Inventor Mohammad R. Abbaszadegan

Mohammad R. Abbaszadegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION AND TREATMENT OF CANCER SUBSETS
    Publication number: 20160058777
    Abstract: Methods of predicting whether or not a tumor will be responsive to IP6 treatment, methods of treating patients with cancer using IP6, methods of predicting the progression of a disease, and kits that facilitate these methods are disclosed.
    Type: Application
    Filed: November 2, 2015
    Publication date: March 3, 2016
    Applicants: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Michael Bittner, Jeffrey M. Trent, Aleksandar Sekulic, Mohammad R. Abbaszadegan
  • Identification and treatment of cancer subsets
    Patent number: 9180136
    Abstract: The present invention relates to methods of selectively treating a patient with skin squamous cell carcinoma are disclosed. Specifically, the methods comprise assessing whether or not the tumor will be responsive to IP6 treatment by using reduced INPP5A expression level as an indicator. The present invention further provides methods of assessing the progression of the disease, and kits that facilitate these methods as disclosed.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: November 10, 2015
    Assignees: The Translational Genomics Research Institute, Mayo Foundation for Medical Education and Research
    Inventors: Michael Bittner, Jeffrey M. Trent, Aleksandar Sekulic, Mohammad R. Abbaszadegan